financetom
Business
financetom
/
Business
/
PureCycle Technologies Gains Preliminary Approval for Shareholder Lawsuit Settlement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PureCycle Technologies Gains Preliminary Approval for Shareholder Lawsuit Settlement
Feb 28, 2025 7:44 AM

10:25 AM EST, 02/28/2025 (MT Newswires) -- PureCycle Technologies ( PCT ) said a US District Court granted preliminary approval of a settlement to resolve shareholder derivative lawsuits and certain shareholder demand letters.

The court in the district of Delaware issued the order on Feb. 18., the company said Friday in a statement.

The settlement includes corporate governance reforms and a $3 million payment by insurers to PureCycle ( PCT ), according to a notice filed with the US Securities and Exchange Commission,

The governance changes involve expanding the board with two independent members, formalizing committee structures and improving compliance and disclosure policies, according to the notice.

A court hearing on the settlement is scheduled for May 1.

Shares of the company rose 3.7% in recent Friday trading.

Price: 9.56, Change: +0.34, Percent Change: +3.69

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IDEAYA Biosciences Reports 'Positive' Interim Phase 1 Data for Cancer Drug; Shares Rise Pre-Bell
IDEAYA Biosciences Reports 'Positive' Interim Phase 1 Data for Cancer Drug; Shares Rise Pre-Bell
Nov 3, 2024
08:06 AM EDT, 10/25/2024 (MT Newswires) -- IDEAYA Biosciences ( IDYA ) reported positive interim expansion data Friday for IDE397 in patients with methylthioadenosine phosphorylase-deletion urothelial cancer and non-small cell lung cancer. The oncology company said that it observed a manageable safety profile with no drug-related serious adverse events or discontinuations at the 30mg once-a-day expansion dose. Shares of IDEAYA...
New US tariffs could prompt Signify to move some production from China, CEO says
New US tariffs could prompt Signify to move some production from China, CEO says
Nov 3, 2024
AMSTERDAM, Oct 25 (Reuters) - Lighting maker Signify is considering moving some of its production out of China if the company is confronted with a new round of U.S. tariffs, its chief executive said on Friday. Signify, the world's biggest maker of lights, is looking at production sites in India, Indonesia and changing existing operations in Mexico, CEO Eric Rondolat...
Market Chatter: AstraZeneca's Former Executives Under Investigation in China
Market Chatter: AstraZeneca's Former Executives Under Investigation in China
Nov 3, 2024
08:08 AM EDT, 10/25/2024 (MT Newswires) -- AstraZeneca's ( AZN ) former senior executive is being investigated by Chinese authorities, Bloomberg reported on Friday, citing local media outlets. The report said Eva Yin, currently the Chief Commercial Officer for Beigene, was recently detained. It added that Yin had worked at AstraZeneca ( AZN ) for over 15 years, including serving...
New US tariffs could prompt Signify to move some production from China, CEO says
New US tariffs could prompt Signify to move some production from China, CEO says
Nov 3, 2024
AMSTERDAM (Reuters) - Lighting maker Signify is considering moving some of its production out of China if the company is confronted with a new round of U.S. tariffs, its chief executive said on Friday. Signify, the world's biggest maker of lights, is looking at production sites in India, Indonesia and changing existing operations in Mexico, CEO Eric Rondolat said on...
Copyright 2023-2025 - www.financetom.com All Rights Reserved